Preclinical evaluation of Janus Kinase inhibitors in atopic dermatitis: Insights from an oxazolone-induced mouse model

被引：0
|
作者：
Zhang, Xiaotuan [1 ]
Wang, Jingjing [1 ]
Zhang, Ya [1 ]
Lu, Dan [1 ]
Gu, Qingyang [1 ]
Zhang, Qiyao [1 ]
机构：
[1] WuXi AppTec Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF IMMUNOLOGY | 2024年 / 212卷 / 01期
关键词：
D O I：
10.4049/jimmunol.212.supp.1415.4840
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
    Singh, Rhea
    Heron, Courtney E.
    Ghamrawi, Rima, I
    Strowd, Lindsay C.
    Feldman, Steven R.
    IMMUNOTARGETS AND THERAPY, 2020, 9 : 255 - 272
  • [32] Saponin from Periploca forrestii Schltr Mitigates Oxazolone-Induced Atopic Dermatitis via Modulating Macrophage Activation
    Zeng, Luting
    Liu, Yingqin
    Xing, Congcong
    Huang, Yijie
    Sun, Xin
    Sun, Guangchen
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [33] ASP015K: A Novel Janus Kinase Inhibitor Demonstrated Potent Efficacy in Adjuvant-Induced Arthritis and Chronic Oxazolone-Induced Dermatitis Model in Rats
    Inami, Masamichi
    Yamazaki, Shunji
    Ito, Misato
    Chida, Noboru
    Nakanishi, Tomonori
    Ooshima, Shinsuke
    Hanaoka, Kaori
    Ohkubo, Keiko
    Shirakami, Shohei
    Inoue, Takayuki
    Fujii, Yasutomo
    Higashi, Yasuyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 47P - 47P
  • [34] An innovative preclinical mouse model of atopic dermatitis
    Bize, C.
    Fremez, C.
    De Pooter, A.
    Lecerf, G.
    Moga, A.
    Fontanie, M.
    Martin, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S215 - S215
  • [35] Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model
    Nam, Gaewon
    Jeong, Se Kyoo
    Park, Bu Man
    Lee, Sin Hee
    Kim, Hyun Jong
    Hong, Seung-Phil
    Kim, Beomjoon
    Kim, Bong-Woo
    ANNALS OF DERMATOLOGY, 2016, 28 (01) : 22 - 29
  • [36] Oxazolone-Induced Immune Response in Atopic Dermatitis Using a Goat Model and Exploration of the Therapeutic Potential of Pomegranate Peel Extract
    Elfadadny, Ahmed
    Samir, Haney
    Mandour, Ahmed S.
    Ragab, Rokaia F.
    Elshafey, Besheer G.
    Alanazi, Fawaz E.
    Hetta, Helal F.
    Alharbi, Ahmad A.
    Albalawi, Abdullah S.
    Aljameel, Suhailah S.
    Alwaili, Maha Abdullah
    Nageeb, Wedad M.
    Emam, Mahmoud H.
    ANIMALS, 2025, 15 (03):
  • [37] Eupatilin, an activator of PPARα, inhibits the development of oxazolone-induced atopic dermatitis symptoms in Balb/c mice
    Jung, Yujung
    Kim, Jin-Chul
    Park, No-June
    Bong, Sim-Kyu
    Lee, Sullim
    Legal, Hyun
    Jin, Li Tai
    Kim, Sang Moo
    Kim, Yong Kee
    Kim, Su-Nam
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 496 (02) : 508 - 514
  • [38] Therapeutic effects of topically-administered guar gum nanoparticles in oxazolone-induced atopic dermatitis in mice
    Ghosh, Nandita
    Mitra, Shinjini
    Banerjee, Ena Ray
    BIOMEDICAL RESEARCH AND THERAPY, 2018, 5 (05): : 2305 - 2325
  • [39] Treatment for atopic dermatitis with Janus kinase inhibitors: useful recommendations from expert opinions
    von Kobyletzki, Laura B.
    Svensson, Ake
    BRITISH JOURNAL OF DERMATOLOGY, 2024,
  • [40] Protective Effects of Topical Administration of Laminarin in Oxazolone-Induced Atopic Dermatitis-like Skin Lesions
    Lee, Tae-Kyeong
    Kim, Dae Won
    Ahn, Ji Hyeon
    Lee, Choong-Hyun
    Lee, Jae-Chul
    Lim, Soon Sung
    Kang, Il Jun
    Hong, Seongkweon
    Choi, Soo Young
    Won, Moo-Ho
    Park, Joon Ha
    MARINE DRUGS, 2022, 20 (11)
12345